NOS-like activity of CeO2 nanozymes contributes to diminishing the vascular plaques

Yuxiang Sun,Tianze Xu,Yike Qian,Qiaoyun Chen,Fei Xiong,Wenxian Du,Li Xu

DOI: https://doi.org/10.1186/s12951-023-02276-5

IF: 10.2

2024-01-03

Journal of Nanobiotechnology

Abstract:Abstract Ceria nanoparticles (CeO 2 NPs) exhibit great potential in cardiovascular disease and nonalcoholic fatty liver disease due to its excellent antioxidant capacity. However, the profitable effect of CeO 2 NPs on many diseases is almost all attributed to the regulation of ROS. Apart from the general antioxidant function, there seems to be no more distinct mechanism to reflect its unique multi-disease improvement effect. Here, we for the first time reveal a new discovery of CeO 2 NPs in mimicking nitric oxide synthase (NOS) by catalyzing L-arginine (L-Arg) to produce nitric oxide (NO) or the derivatives. NOS-like activity of CeO 2 NPs is original and associated with multiple factors like substrate concentration, pH, temperature and time, etc. where oxygen vacancy ratio plays a more critical role. Meanwhile, NOS-like activity of CeO 2 NPs successfully elevates NO secretion in endothelial cells and macrophages without expanding eNOS/iNOS expression. Importantly, NOS-like activity of CeO 2 NPs and the responsive endogenous NO promote the re-distribution of blood lipids and stabilize eNOS expression but suppress iNOS, thus collectively alleviate the accumulation of vascular plaque. Altogether, we provide a new angle of view to survey the outstanding potential of CeO 2 NPs, apart from the inevitable antioxidant capacity, the covert but possible and more critical NOS-like enzymatic activity is more noteworthy.

biotechnology & applied microbiology,nanoscience & nanotechnology

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to explore new mechanisms of cerium dioxide nanoparticles (CeO2NPs) in cardiovascular diseases, especially their ability to mimic nitric oxide synthase (NOS). Specifically, for the first time, researchers have revealed that CeO2NPs exhibit NOS - like activity by catalyzing L - arginine (L - Arg) to produce nitric oxide (NO) or its derivatives. This NOS - like activity is not only related to multiple factors such as substrate concentration, pH value, temperature and time, but also the proportion of oxygen vacancies plays a more crucial role.

The research further shows that the NOS - like activity of CeO2NPs can increase the secretion level of NO in endothelial cells and macrophages without increasing the expression of eNOS/iNOS. More importantly, the NOS - like activity of CeO2NPs and the endogenous NO induced by it can promote the redistribution of blood lipids, stabilize the expression of eNOS, and at the same time inhibit the expression of iNOS, thus collectively acting to reduce the accumulation of vascular plaques. This provides a new perspective for understanding the unique behavior of CeO2NPs in metabolic disorders and shows its great potential in new applications.